Friday 6 November 2026 Export ONC’s income statement to Excel — free account

BeOne Medicines Ltd. - Sponsored ADR

BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.

Revenue: +33.8%
EPS: +143.7%
Free cash flow: +33.6%
Total debt: +491.3%

Quarter to September 2026, against a year earlier

409.13 21.88 +5.65%

Follow ONC

Alert me

Market cap: $40.4B
P/E: 65.9×
Fwd P/E: 48.8×
Dividend yield: —
F-score: 7/9
Altman Z: 5.25
Beneish M: −2.73
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

BeOne Medicines Ltd. - Sponsored ADR 8-K filed Jun 11, 2026

Period ended Jun 11, 2026 · Filed Jun 11, 2026 · accepted 4:13 PM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits

Red flags

Officer departure Jun 11, 2026
BeOne Medicines Ltd. - Sponsored ADR reported the departure of an officer or director

8-K filed Jun 11, 2026 · The filing · sec.gov

BeOne Medicines Ltd. - Sponsored ADR 8-K filed Jun 11, 2026

Red flags

Stockrow Weekly